rs149000560
Variant names:
Variant summary
Our verdict is Benign. The variant received -19 ACMG points: 1P and 20B. PP3BP4_StrongBP6_Very_StrongBS1BS2
The NM_031471.6(FERMT3):c.130G>A(p.Gly44Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00766 in 1,613,364 control chromosomes in the GnomAD database, including 86 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0057 ( 6 hom., cov: 33)
Exomes 𝑓: 0.0079 ( 80 hom. )
Consequence
FERMT3
NM_031471.6 missense
NM_031471.6 missense
Scores
9
5
4
Clinical Significance
Conservation
PhyloP100: 9.32
Publications
16 publications found
Genes affected
FERMT3 (HGNC:23151): (FERM domain containing kindlin 3) Kindlins are a small family of proteins that mediate protein-protein interactions involved in integrin activation and thereby have a role in cell adhesion, migration, differentiation, and proliferation. The protein encoded by this gene has a key role in the regulation of hemostasis and thrombosis. This protein may also help maintain the membrane skeleton of erythrocytes. Mutations in this gene cause the autosomal recessive leukocyte adhesion deficiency syndrome-III (LAD-III). Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jan 2010]
FERMT3 Gene-Disease associations (from GenCC):
- leukocyte adhesion deficiency 3Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -19 ACMG points.
PP3
Multiple lines of computational evidence support a deleterious effect 10: AlphaMissense, BayesDel_noAF, Cadd, Dann, Eigen, FATHMM_MKL, phyloP100way_vertebrate, PROVEAN, REVEL, REVEL [when max_spliceai, MetaRNN, MutationTaster was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.011366427).
BP6
Variant 11-64207494-G-A is Benign according to our data. Variant chr11-64207494-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 195388.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00566 (862/152236) while in subpopulation NFE AF = 0.00832 (566/68012). AF 95% confidence interval is 0.00775. There are 6 homozygotes in GnomAd4. There are 397 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 6 AR gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| FERMT3 | NM_031471.6 | c.130G>A | p.Gly44Arg | missense_variant | Exon 2 of 15 | ENST00000345728.10 | NP_113659.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| FERMT3 | ENST00000345728.10 | c.130G>A | p.Gly44Arg | missense_variant | Exon 2 of 15 | 1 | NM_031471.6 | ENSP00000339950.5 |
Frequencies
GnomAD3 genomes AF: 0.00567 AC: 863AN: 152118Hom.: 6 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
863
AN:
152118
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00600 AC: 1501AN: 250244 AF XY: 0.00607 show subpopulations
GnomAD2 exomes
AF:
AC:
1501
AN:
250244
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00787 AC: 11493AN: 1461128Hom.: 80 Cov.: 31 AF XY: 0.00773 AC XY: 5619AN XY: 726852 show subpopulations
GnomAD4 exome
AF:
AC:
11493
AN:
1461128
Hom.:
Cov.:
31
AF XY:
AC XY:
5619
AN XY:
726852
show subpopulations
African (AFR)
AF:
AC:
58
AN:
33476
American (AMR)
AF:
AC:
175
AN:
44688
Ashkenazi Jewish (ASJ)
AF:
AC:
749
AN:
26070
East Asian (EAS)
AF:
AC:
0
AN:
39688
South Asian (SAS)
AF:
AC:
158
AN:
86186
European-Finnish (FIN)
AF:
AC:
100
AN:
53308
Middle Eastern (MID)
AF:
AC:
263
AN:
5744
European-Non Finnish (NFE)
AF:
AC:
9480
AN:
1111596
Other (OTH)
AF:
AC:
510
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
676
1351
2027
2702
3378
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
368
736
1104
1472
1840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00566 AC: 862AN: 152236Hom.: 6 Cov.: 33 AF XY: 0.00533 AC XY: 397AN XY: 74422 show subpopulations
GnomAD4 genome
AF:
AC:
862
AN:
152236
Hom.:
Cov.:
33
AF XY:
AC XY:
397
AN XY:
74422
show subpopulations
African (AFR)
AF:
AC:
59
AN:
41548
American (AMR)
AF:
AC:
83
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
93
AN:
3468
East Asian (EAS)
AF:
AC:
0
AN:
5164
South Asian (SAS)
AF:
AC:
2
AN:
4826
European-Finnish (FIN)
AF:
AC:
5
AN:
10606
Middle Eastern (MID)
AF:
AC:
16
AN:
294
European-Non Finnish (NFE)
AF:
AC:
566
AN:
68012
Other (OTH)
AF:
AC:
15
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
45
90
135
180
225
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
30
ALSPAC
AF:
AC:
28
ESP6500AA
AF:
AC:
9
ESP6500EA
AF:
AC:
83
ExAC
AF:
AC:
689
Asia WGS
AF:
AC:
5
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
May 28, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Leukocyte adhesion deficiency 3 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
Jun 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
FERMT3: BS1, BS2 -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Pathogenic
DANN
Pathogenic
DEOGEN2
Benign
T;D;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
D;D;D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
.;M;M
PhyloP100
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D;D
REVEL
Pathogenic
Sift
Uncertain
D;D;D
Sift4G
Uncertain
D;D;D
Polyphen
1.0, 1.0
.;D;D
Vest4
0.87, 0.89
MutPred
Gain of MoRF binding (P = 0.0028);Gain of MoRF binding (P = 0.0028);Gain of MoRF binding (P = 0.0028);
MVP
MPC
1.3
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.